In this episode of “Moving Medicine Forward” – The Podcast, Mike Vieth, CTI Board Member and partner at E Gateway Capital, and Tim Schroeder, CTI CEO and Chairman, explore key topics in clinical trial funding. They discuss the role of venture capital in overcoming funding challenges, balancing high-risk investments, and supporting clinical research beyond financial backing. They also dive into how data analytics and AI are shaping investment decisions and the importance of CROs in connecting venture capital with small biotech companies. Tune in for insights on how venture capital influences clinical research and the future landscape in 2025.